Newsroom for Journalists & Media Relations

BEAMER: Quick Insights About The Project

BEAMER in The Spotlight

PORTUGAL: Universidade do Porto lidera projeto internacional de 12 milhões que visa investigar adesão terapêutica

SPAIN: Inteligencia artificial para mejorar la adherencia y eficacia de los tratamientos médicos

Trending News

Coming Soon

Supported by a grant from IMI, the project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 101034369. This joint undertaking receives support from the European Union’s Horizon 2020 research and innovation programme, the European Federation of Pharmaceutical Industries and Associations [EFPIA] and Link2Trials. The total budget is 11.9 M€ for a project duration of 60 months.

Information on this website reflects project owner’s views and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained therein.

Who’s Behind BEAMER
Subscribe to Newsletter
Press Office

Privacy Policy and Cookies

Follow us: